Abstract
Implantation numbers of conventional antibradycardia pacemakers (PM), implantable cardioverter defibrillators (ICD) and cardiac resynchronisation therapy PMs and ICDs (CRT-P and D) have shown a minimal increase till 2017. Between 2017–2019 the implantation numbers have remained on a steady state level, the numbers of ILR, CRT-D and conventional ICDs have shown a slight increase, moreover the ratio of CRT-P against CRT-D has decreased. Year of 2020 was a special year due to the SARS-CoV2 pandemic, since the primary implantations without urgent indication have been limited and been postponed. In the last 2 years close speciality cooperation between the National Health Fund and the Board of the Hungarian Society of Cardiology Working Group of Cardiac Pacing and Electrophysiology established the reimbursement of implantation of leadless pacemakers and subcutaneous ICDs. Since 2020 a new special reimbursement possibility for His-bundle pacing modality for chronic heart failure patients without LBBB.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
